Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by Health Canada for the treatment of ...

The oxytocin system – which helps release breast milk and strengthens the bond between mother and baby – may be affected ...

Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose: London Monday, March 24, 2025, 13:00 Hrs [IST] Hikma Pharmac ...

In terms of the newest collaboration, the health care professionals said they decided that having all the services under one ...

The oxytocin system - which helps release breast milk and strengthens the bond between mother and baby - may be affected ...

Hikma Pharmaceuticals (HKMPF) announces the approval of KLOXXADO Nasal Spray 8 mg, by Health Canada for the treatment of known or suspected ...

Breastfeeding mothers with postnatal depression show disruptions in oxytocin systems, impacting bonding and milk release.

The oxytocin system -- which helps release breast milk and strengthens the bond between mother and baby -- may be affected during breastfeeding in mothers experiencing postnatal depression.

However, while oxytocin was seen to increase in the breast milk of women without postnatal depression after using a nasal spray containing the hormone, this effect was reduced in mothers ...

The oxytocin system-which helps release breast milk and strengthens the bond between mother and baby-may be affected during breastfeeding in mothers experiencing postnatal depression, finds a ...